A statement from Kendalle Burlin O’Connell, MassBio CEO & President, on the announcement of ARPANET-H and Massachusetts’ selection as one of three regional hubs:
“Massachusetts plays an outsized role in addressing the world’s unmet medical needs, and the Biden Administration’s decision to locate the Investor Catalyst Hub for ARPA-H here in Cambridge puts the agency in a position to tap into the talent, funding, institutions, and innovation that are our ecosystem’s greatest assets. Over the past 16 months, Governor Healey and her administration, our federal delegation, the members of the CHARM Coalition—including the Massachusetts Life Sciences Center and MassMEDIC, have made the case for how the Commonwealth can deliver on the lofty goals of ARPA-H. Today, our local biotechs stand ready to compete for the dollars that will help to unlock the cures and therapies that will change the course of human health.”
###